CSIR's 2024 Healthcare Breakthroughs: Advancing Cancer Detection, Genetic Disorders, and Neurodegenerative Disease Research

Dr. Sandip Shah Appointed Chairman of NABL: A Visionary Leader in Indian Healthcare

Global and Indian Genetic Testing Market Trends in 2025

Mankind Pharma and Innovent Biologics Partner to Launch Groundbreaking PD-1 Immunotherapy in India

Duchenne Muscular Dystrophy: Diagnosis, Treatment, and Emerging Therapies

Ikena Oncology and Inmagene Biopharmaceuticals Announce Merger to Form ImageneBio

Fujirebio and Eisai Partner to Advance Diagnostics for Neurodegenerative Diseases

European Commission Approves Opdivo® Plus Yervoy® for First-Line Treatment of MSI-H or dMMR mCRC

Deerfield Management to Acquire Singular Genomics for $20 Per Share in All-Cash Deal

EU Approval of Tagrisso Sets New Standard for EGFR-Mutated NSCLC Treatment

Aurobindo Pharma’s Subsidiary CuraTeQ Secures UK Approval for Bevacizumab Biosimilar

SCG Cell Therapy Partners with A*STAR BTI and NATi to Advance RNA-Based Therapeutics

Korea's National Bio Big Data Project: Advancing Precision Medicine with Macrogen and Illumina

GST Exemption Announced for Cancer Treatment Gene Therapy

AIIMS Develops Affordable CAR-T Cell Therapy for Multiple Myeloma

Home
/
insight
/
details

Global and Indian Genetic Testing Market Trends in 2025

NextEdge Admin

27 Dec 2024

3 min 8 sec

Global Trends

Advancements in genetic testing technologies, such as next-generation sequencing (NGS) and polymerase chain reaction (PCR), have significantly improved the accuracy, efficiency, and affordability of genetic analyses, driving the global market forward. Companies like Qiagen are leveraging these innovations, aiming for a 7% annual growth rate in sales until 2028 through their focus on PCR-based genetic testing machines and diagnostic tests for cancer and infectious diseases.
Cited Source: Reuters

The integration of artificial intelligence (AI) with genetic data is opening new opportunities in the sector. Tempus AI, a company specializing in AI-driven clinical and molecular data, has gained recognition from Wall Street analysts for its advanced diagnostic tools, which are anticipated to drive considerable revenue growth in the near future.
Cited Source: Reuters

India-Specific Trends

The genetic testing market in India is rapidly expanding, with the market valued at USD 69.24 million in 2024 and projected to reach USD 103.70 million by 2030, growing at a compound annual growth rate (CAGR) of 6.89%.
Cited Source: TechSci Research

The direct-to-consumer (DTC) genetic testing segment is also gaining momentum. It is expected to grow at a CAGR of 22.8% from 2024 to 2030, reaching a projected revenue of USD 154.1 million by 2030.
Cited Source: Grand View Research

Key Growth Factors in India:

Increased Awareness: Growing public acceptance of genetic testing for diagnosing genetic disorders and diseases.
Technological Advancements: Adoption of advanced technologies like NGS and PCR has enhanced testing precision and efficiency.
Prevalence of Genetic Disorders: Rising cases of genetic and chronic diseases are fueling demand for testing services.
Government Initiatives: Investments in healthcare infrastructure and personalized medicine are fostering market growth.

Conclusion

Globally and in India, the genetic testing market is set for substantial growth by 2025. Key drivers include advancements in NGS and AI integration, increased public awareness, and strategic healthcare initiatives.